A panel at the SGO 2018 Annual Meeting on Women’s Cancer convened to achieve consensus on PARP inhibitor use for the treatment and maintenance of ovarian cancer in the context of current standards.
Some oncologists may be more likely to prescribe certain cancer medicines when they receive payments from the companies that make these drugs.

By Will Boggs MD

NEW YORK (Reuters Health) - Tumor sequencing offers advantages over current approaches to Lynch-syndrome screening in patients with colorectal cancer (CRC), researchers report.

In patients with cancer who are depressed, a targeted treatment program improves depression and quality of life but does not extend life.
In a recent study, a combination therapy for the treatment of relapsed or refractory multiple myeloma proved to be as beneficial in routine clinical practice as it did in clinical trials used to support its approval.
A recent study found that patients with non-Hodgkin lymphoma who received CAR-T therapy benefited, with an overall response rate of what percentage after a median of 15.4 months?
A panel of four kallikrein markers improves prediction of 20-year risk of prostate cancer death in middle-aged men with elevated prostate-specific antigen.
A streamlined emergency department clinical pathway appears to improve care and reduce admission rates for children presenting with anaphylaxis
A recent study sought to determine if clinical benefits of novel anticancer drugs have increased over time in conjunction with increasing costs.
The American Society for Radiation Oncology has provided an update to its clinical guideline for palliative-intent radiation therapy in patients with lung cancer, recommending concurrent chemotherapy for some patients with stage III disease.